EDGAR Filing Documents for 0001144204-17-010403

Form 8-K - Current report:

SEC Accession No. 0001144204-17-010403

Filing Date

2017-02-22

Accepted

2017-02-22 16:30:38

Documents

Period of Report

2017-02-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v460173_8k.htm	8-K	31797
2	EXHIBIT 4.1	v460173_ex4-1.htm	EX-4.1	61729
3	EXHIBIT 4.2	v460173_ex4-2.htm	EX-4.2	64546
4	EXHIBIT 10.1	v460173_ex10-1.htm	EX-10.1	30970
5	EXHIBIT 10.2	v460173_ex10-2.htm	EX-10.2	39288
	Complete submission text file	0001144204-17-010403.txt		229759

Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121

Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (908) 864-4444

Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)